Everolimus is a high-precision, dual-action medication classified as a . It is primarily used to treat certain types of advanced cancer and to prevent organ rejection in transplant recipients by regulating cell growth and the body's immune response. Core Therapeutic Uses

: It is available in an oral tablet form, allowing for consistent drug delivery without the need for frequent injections. Safety and Side Effects

Everolimus is prescribed for several serious conditions where targeted therapy is required:

: In oncology, it interferes with the division of cancer cells, which are then naturally destroyed by the body. In clinical studies for neuroendocrine tumors, it has shown high disease control rates.

: It is also used for managing tuberous sclerosis complex (TSC) and related benign tumors. Key Benefits

Due to its potent nature, everolimus must be used under strict medical supervision. Common side effects include: Everolimus (Afinitor) | Cancer drugs - Cancer Research UK

: Unlike conventional chemotherapy, everolimus focuses on specific cellular pathways (mTOR), which helps minimize damage to healthy surrounding cells.

: It is used to treat hormone receptor-positive, HER2-negative advanced breast cancer , advanced kidney cancer (renal cell carcinoma), and certain neuroendocrine tumors found in the pancreas, lungs, or gastrointestinal tract.